SCHEMBL4874044

SCHEMBL4874044

CCc1ccc(S(=O)(=O)Nc2ccc(SC3CCN(C)CC3)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
UCHL1 P09936 1/20 0.54
MAPT P10636 3/20 0.51
TP53 P04637 1/20 0.51
KMT2A Q03164 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HTR2A P28223 3/20 0.47
HTR2C P28335 3/20 0.47
DRD2 P14416 3/20 0.46
DRD3 P35462 3/20 0.46
HTR6 P50406 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MEN1 O00255 2/20 0.45
LMNA P02545 3/20 0.45
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4874970 0.87 DRD2 (0.56) ALDH1A1MAPTTP53HTR2AHTR2C
SCHEMBL4874458 0.87 ALDH1A1 (0.44) ALDH1A1MAPTTP53KMT2AHTR2A
SCHEMBL4866321 0.87 ALDH1A1 (0.57) ALDH1A1MAPTTP53KMT2AL3MBTL1
SCHEMBL4876385 0.86 HTR6 (0.49) ALDH1A1MAPTTP53KMT2AHTR2A
SCHEMBL4873695 0.86 ALDH1A1 (0.58) ALDH1A1MAPTTP53KMT2AL3MBTL1
SCHEMBL4876689 0.86 CES1 (0.54) ALDH1A1MAPTKMT2AL3MBTL1HTR2A
SCHEMBL4876786 0.84 ALDH1A1 (0.56) ALDH1A1MAPTKMT2AHTR2AHTR2C
SCHEMBL6617076 0.84 ALDH1A1 (0.60) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL4876622 0.83 ALDH1A1 (0.60) ALDH1A1KMT2AL3MBTL1CYP3A4MEN1
SCHEMBL4869725 0.82 HTR2A (0.51) ALDH1A1MAPTTP53HTR2ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7408067-B2 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK + CO., INC. (US) 2008-08-05 US disclosed
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK SHARP & DOHME CORP. 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors CHRNG, CHRNA4, CHRNB4 ALDH1A1 1088/4885UCHL1 2238/4885MAPT 3850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.